English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
ENT & Allergy of New Orleans
+
Community
Patient Daily
| Aug 29, 2024
ENT & Allergy of New Orleans‘ Dr. Pippin: ‘Our practice is focused on the patients’ needs’
+
Technology/Innovation
Patient Daily
| Dec 15, 2023
New Orleans doctor says allergy treatment consists of 'allergy shots' or 'sublingual immunotherapy'
Trending
+
Pharmaceuticals
Patient Daily
| Aug 6, 2026
FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+
Regulatory
M. Y. Bailey
| Aug 7, 2026
PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports
| Aug 10, 2026
SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+
Pharmaceuticals
Patient Daily
| Aug 7, 2026
Researchers develop computer model linking brain chemistry to neural activity patterns